Innovation

Illumina Inc., in collaboration with Nashville Biosciences LLC, a leading clinical and genomic data company and wholly owned subsidiary of Vanderbilt University Medical Center, have announced the five founding new members of the Alliance for Genomic Discovery.

Here are frequently asked questions about Vanderbilt University Medical Center's Alliance for Genomic Discovery.

Jenny Slayton, DNP, RN, received the Outstanding Operational Partner Award recently at the Vanderbilt Symposium on Implementation Research in the Learning Health System.

A new project, funded by the National Institutes of Health (NIH), National Institute on Deafness and Other Communication Disorders (NIDCD) and led by Aaron Moberly, MD, and Metin Gurcan, PhD, professor and director of the Center for Biomedical Informatics and the Clinical Image Analysis Lab at Wake Forest University School of Medicine, aims to develop machine learning applications to analyze eardrum videos collected with a digital otoscope.

Vanderbilt pediatric orthopaedic surgeons are the first in Tennessee to perform an innovative procedure to treat scoliosis that uses the patient’s own growth to correct the curve.

Vanderbilt University Medical Center is part of a select group of health systems nationwide brought together to accelerate the implementation of medical research results that will improve patient outcomes.

Nashville Biosciences LLC, a wholly owned subsidiary of Vanderbilt University Medical Center, and Illumina Inc., a global leader in DNA sequencing and array-based technologies, today announced an agreement with Amgen, a global biopharmaceutical company, to whole-genome sequence approximately 35,000 DNA samples.